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1. Introduction1
Arrhythmia is a common disease in Department of Inter-
nal Medicine It is a typical clinical manifestation of many 
cardiovascular diseases. It has a certain incidence rate in pa-
tients with coronary heart disease, myocarditis, cardiomyo-
pathy and normal healthy population. The clinical manifes-
tations are diverse, mainly for the heart palpitations or low 
blood volume caused dizziness, syncope and even death [1]. 
It is a serious cardiovascular disease, which has a serious im-
pact on public health and quality of life. In order to explore 
the clinical effect of the treatment of cardiac arrhythmia, 
100 cases of arrhythmia in our hospital were studied, and 
the clinical effect of two kinds of treatment methods for the 
treatment of arrhythmia were compared. 
2. Materials and methods
2.1. General information
Between January 2011 January to 2013, 100 patients of ar-
rhythmia was selected. All admission patients showed the 
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manifestations of chest tightness, shortness of breath, fa-
tigue and heart palpitations. All patients were diagnosed 
as arrhythmias according to the ECG findings and Holeter 
standard diagnosis. In this group of patients, 48 cases 
were male and 52 were female, aged 32−80 years old, with 
average age of 56 years old. Subjects was experienced ar-
rhythmia for the duration 3 days to 10 years, including 30 
cases, 10 cases of atrial fibrillation, 13 cases of atrial fibril-
lation, 12 cases of pulmonary heart disease, 20 cases of 
pulmonary heart disease, 6 cases of valvulopathy, 14 cases 
of myocarditis, 6 cases of dilated cardiomyopathy, 4 cases 
of hyperthyroid heart disease. According to the principle of 
random grouping, 100 patients were divided into observa-
tion group and control group, 50 cases in each group, two 
groups of patients in gender, age and condition of the differ-
ence was not statistically significant p > 0.05, comparable.
2.2. Method
In the control group, 50 patients were treated with 150 mg 
propafenone, 3 times per day, and the observation group 
was treated with stable heart granules, 1 sachet per time 
and 3 times a day. The two groups were treated with 3 
weeks as a course of treatment, the clinical symptoms im-
provement, ECG test results and adverse reactions were 
observed and compared.
2.3. Curative effect standard
In accordance with the administration of traditional Chi-
nese medicine disease diagnosis standard of arrhythmia 
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treatment effect of division, (1) Cure: Clinical diagnosis 
or disappeared completely, the ECG returned to normal 
and not relapse within 1 month of drug withdrawal; (2) 
Improved: Compared with before treatment, the clinical 
symptoms improved significantly, the electrocardiogram 
showed improved more than 50%; (3) Healed: Clinical 
symptom does not have clear improvement even heavier, 
electrocardiogram examination results compared with 
those before treatment did not reduce even heavier. And 
the total effective rate was calculated as the sum of the cure 
rate and the improvement rate and the rate of improve-
ment [2]. Total effective = [(1) + (2)] / [(1) + (2) + (3)] * 
100%.
2.4. Statistical methods
SPSS 13.0 statistical software was used for statistical analy-
sis, the comparison between groups was carried out by t, 
and the measurement data were ( x  ± s). The data were 
tested by p, and the x2 was statistically significant.
3. Results
3.1. Comparison of treatment effect of two groups of 
patients
Treatment effect comparison, observation group cured 32 
cases, improved 15 cases, invalid 3 cases, the total effective 
rate was 94%, control group of 21 cases, 17 cases improved, 
11 cases ineffective, the total effective rate was 78%, the 
difference was significant, with statistical significance p < 
0.05 (Table 1).
In 50 patients of observation group, there were 4 cases of 
adverse reactions, including 3 cases of adverse reactions, 
8% cases of gastrointestinal reaction, 1 cases of adverse re-
actions, adverse reactions occurred in 50 cases, including 6 
cases of sinus tachycardia, 2 cases of I degree atrioventricu-
lar block, 2 cases of P-R interval, adverse reaction rate was 
20%. The incidence of adverse reactions in the two groups 
were significantly different, compared with the statistical 
significance p < 0.05.
3.2. Dynamic ECG changes in 24 h
Before and after treatment in both groups of patients with 
24 h dynamic electrocardiogram changes were observed. 
Before treatment, ischemia times for observation group 
were (28 ± 7) times/24 h, ventricular premature beat (2081 
± 790) times/24 h, atrial premature beat (1234 ± 268) 
times/24 h less than; while after treatment patients’ isch-
emia times (8 ± 6) times/24 h, ventricular premature beat 
(864 ± 261) times/24 h, atrial premature beat (420 ± 310) 
times/24 h. Whereas before ischemia time for the treat-
ment patients in control group were (29 ± 7) times/24 h, 
ventricular premature beat (2102 ± 710) times/24 h, atrial 
premature beat (1200 ± 280) times/24 h; while after treat-
ment number of patients’ ischemia (15 + 9) times/24 h 
and ventricular premature beat (1560 ± 385) times/24 h, 
atrial premature beat (898 ± 420) times/24 h. There was 
no significant difference between 24 h dynamic electro-
cardiogram changes of two groups and (p > 0.05), and the 
difference of 24 h in the observation group and the control 
group was, (p < 0.05) which was statistically significant dif-
ferent. Specific results are shown in table 2.
4. Discussion
Arrhythmia refers cardiac impulse and impulse conduction 
disturbance the affect the normal rhythm of heart beating 
which caused by various reasons. The main clinical mani-
festations include, flustered, palpitations, insomnia, chest 
pain, shortness of breath and fatigue. Besides it is a seri-
ous cause of sudden death in patients and the pathogenesis 
rate in China was about 0.9%, and it became the important 
reason that resulting in the death of the elderly patients 
with cardiovascular diseases. The common causes include: 
cardiomyopathy, coronary heart disease, pulmonary heart 
Table 1. The effect of the observation group and the control group [n (%)].
Group Cases Cure Improved Invalid Total efficiency
Observation group 50 32 (64.00) 15 (30.00) 3 (0.06) 47 (94.0)
Control group 50 21 (42.00) 17 (34.00) 11 (22.00) 38 (78.0)
x2 - 4.857487 0.123824 5.315615 5.315615
p - 0.027526 0.668108 0.021135 0.021135
Table 2. Dynamic electrocardiogram changes before and after treatment in the two groups ( x  ± s, 24 h).
Group Cases
Before treatment After treatment
Ischemia 
times
Ventricular 
premature beat
Atrial 
premature beat
Ischemia 
times
Ventricular 
premature beat
Atrial 
premature beat
Observation 
group
50 28 ± 7 2081 ± 790 1234 ± 268 8 ± 6 864 ± 261 420 ± 310
Control group 50 29 ± 7 2102 ± 710 1200 ± 280 15 ± 9 1560 ± 385 898 ± 420
t - 1.236545 1.654870 2.698750 11.236548 12.986541 13.789562
p - 1.232352 0.986543 1.569874 0.004562 0.003985 0.000011
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disease, and other organic heart disease, electrolyte and 
acid-base balance disorders, autonomic nervous function 
disorders, endocrine disorders, etc. Moreover, some factor 
included, frequent number of smoking, drinking, concen-
trated coffee or tea, over exertion and mental stress and 
other [3]. Under normal circumstances, impulse of heart 
from the sinoatrial node, followed by atrial, atrioventricu-
lar node and atrioventricular bundle conduction to the 
ventricle muscle, causing cardiac rhythmic contraction. 
In the course of drug or pathological condition, impulse 
is affected in the formation or transmission of the disease, 
which leads to the occurrence of arrhythmia. The common 
types include the tachycardia, sinus tachycardia, premature 
beat, ventricular tachycardia, atrial or ventricular fibrilla-
tion. During the course of anti-arrhythmia drugs for ar-
rhythmia treatment, the improper use of drugs, will lead to 
further increase in cardiac arrhythmia, or drugs although 
reduce the incidence of arrhythmia, but increased the rate 
of arrhythmia, that bring threatening to health and life. 
Therefore, the current focus should put on the treatment 
of arrhythmia that effective inhibition of arrhythmia, with 
less adverse reactions, and no increase in mortality.
According to the theory of traditional Chinese medicine 
(TCM), arrhythmia belongs to palpitations, pathological 
mechanism usually is the deficiency in origin and excess in 
superficiality, intermingled deficiency and excess, clinical 
manifestations of blockage of cardiovascular and deficien-
cy of both vital and Yin. Stable heart granule is a new tra-
ditional Chinese medicine, its main ingredient is sealwort, 
Codonopsis pilisula, spikenard, pseudo-ginseng, lamber 
etc. Within the prescription, sealwort responsible for sup-
plementing vital and nourishing Yin, the effect of nourish 
the kidney and strengthen the essence; Codonopsis pilo-
sula strengthening spleen and tonifying lung, invigorat-
ing spleen-stomach and replenishing vital; spikenard play 
the role of promoting blood circulation to remove blood 
stasis; lamber have the effect of calming, benefit internal 
organs, and elimination extravasated blood. A variety of 
drug combination to supplementing vital and nourishing 
Yin, promoting blood circulation to remove blood stasis, 
and calming effect [4]. Modern pharmacological research 
show that valerian ketone is the main component of 
spikenard, that act on sodium channels, potassium chan-
nels and L-type calcium channel has significant block ef-
fect, can effectively prolong the action potential duration, 
improve arrhythmia condition; sealwort, Codonopsis 
pilisula and pseudo-ginseng can dilate coronary artery, 
increase coronary blood flow, inhibit platelet aggregation, 
reduce blood viscosity and catecholamine excitement, 
thereby reducing heart rate and myocardial oxygen con-
sumption, strengthens the heart, improve microcircula-
tion, blood pressure adjustment effect, and restoring nor-
mal rhythm [5].
In this group, 50 patients in the observation group were 
treated with stable heart granules. The total effective rate 
was 94%, the control group was treated with propafenone, 
the total effective rate was 78%, the difference of the two 
groups was statistically significant. The results showed that 
the effect of the Stable heart granule treatment of cardiac 
arrhythmia was more obvious than propafenone treatment 
and the incidence of adverse reactions was low. The effect 
was safe and reliable.
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